Search Results - "Kefala, D."

FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF IG-TREGS FOR GVHD PREVENTION by Lysandrou, M., Kefala, D., Christofi, P., Liga, M., Miggos, A., Papagregoriou, C., Vlachonikola, E., Savvopoulos, N., Zacharioudaki, V., Vallianou, I., Sagiadinou, E., Tsokanas, D., Theodorelou, R., Papadopoulou, A., Triantafyllou, E., Sakellari, I., Costeas, P., Chatzidimitriou, A., Yannaki, E., Spyridonidis, A.

“…Our approach for GvHD prevention aims to mimic the paradigm of fetomaternal tolerance. HLA-G is an immunomodulatory molecule expressed in the placenta to…”
Get full text

Immunotherapy: PRE-CLINICAL DEVELOPMENT OF A DECITABINE-INDUCED REGULATORY HLAG+CD4+-T CELL-ENRICHED CELL PRODUCT (IG-TREG) AGAINST GRAFT-VS-HOST-DISEASE by Kefala, D., Lysandrou, M., Christofi, P., Pieridou, C., Papayanni, P.G., Savvopoulos, N., Kyriakou, M., Chatzidaniil, A., Stamou, P., Anagnostopoulos, A., Papadopoulou, A., Costeas, P., Yannaki, E., Spyridonidis, A.

Get full text

Ventilator-Associated Pneumonia Is Characterized by Excessive Release of Neutrophil Proteases in the Lung by Wilkinson, Thomas S., PhD, Conway Morris, Andrew, MD, PhD, Kefala, Kallirroi, MD, O'Kane, Cecilia M., MD, PhD, Moore, Norma R., BSc, Booth, Nuala A., PhD, McAuley, Daniel F., MD, Dhaliwal, Kevin, MD, Walsh, Timothy S., MD, Haslett, Christopher, MD, Sallenave, Jean-Michel, PhD, Simpson, A. John, MD, PhD

“…Background Ventilator-associated pneumonia (VAP) is characterized by neutrophils infiltrating the alveolar space. VAP is associated with high mortality, and…”
Get full text